Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 5389272, 9 pages
https://doi.org/10.1155/2017/5389272
Research Article

Effects of Total Flavone from Rhododendron simsii Planch. Flower on Postischemic Cardiac Dysfunction and Cardiac Remodeling in Rats

Department of Pharmacology, Anhui Medical University, Hefei, Anhui 230032, China

Correspondence should be addressed to Zhiwu Chen; moc.361@wzmrahphc

Received 11 December 2016; Revised 29 March 2017; Accepted 2 April 2017; Published 8 June 2017

Academic Editor: Juntra Karbwang

Copyright © 2017 Xinqi Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Heusch, P. Libby, B. Gersh et al., “Cardiovascular remodelling in coronary artery disease and heart failure,” The Lancet, vol. 383, no. 9932, pp. 1933–1943, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Pol, A. Muller, M. J. Zuidwijk et al., “Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition,” Endocrinology, vol. 152, no. 2, pp. 669–679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Kern, H.-Z. Feng, H. Wei, S. Cala, and J.-P. Jin, “Up-regulation of alpha-smooth muscle actin in cardiomyocytes from non-hypertrophic and non-failing transgenic mouse hearts expressing N-terminal truncated cardiac troponin I,” FEBS Open Bio, vol. 4, pp. 11–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L.-L. Chen, H. Yin, and J. Huang, “Inhibition of TGF-β1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis,” Cardiovascular Pathology, vol. 16, no. 4, pp. 221–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Hayashidani, H. Tsutsui, M. Ikeuchi et al., “Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 285, no. 3, pp. H1229–H1235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Chen, D. Li, X. Zhang, P. L. Hermonat, and J. L. Mehta, “Anoxia-reoxygenation stimulates collagen type-1 and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-γ ligand pioglitazone,” Journal of Cardiovascular Pharmacology, vol. 44, no. 6, pp. 682–687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kleinbongard, R. Schulz, and G. Heusch, “TNFα in myocardial ischemia/reperfusion, remodeling and heart failure,” Heart Failure Reviews, vol. 16, no. 1, pp. 49–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kong, P. Christia, and N. G. Frangogiannis, “The pathogenesis of cardiac fibrosis,” Cellular and Molecular Life Sciences, vol. 71, no. 4, pp. 549–574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Shi, Q. Han, J. Xu, W. Liu, T. Chu, and L. Zhao, “Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway,” Gene, vol. 583, no. 1, pp. 8–14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Esposito, C. Perrino, A. Cannavo et al., “EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy,” Basic Research in Cardiology, vol. 106, no. 4, pp. 577–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Satoh, Y. Fukumoto, and H. Shimokawa, “Rho-kinase: important new therapeutic target in cardiovascular diseases,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 2, pp. H287–H296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Brakebusch and R. Fässler, “The integrin-actin connection, an eternal love affair,” The EMBO Journal, vol. 22, no. 10, pp. 2324–2333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-H. Zhao, C. Laschinger, P. Arora, K. Szászi, A. Kapus, and C. A. McCulloch, “Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway,” Journal of Cell Science, vol. 120, no. 10, pp. 1801–1809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Lei, D. Wu, J.-Y. Wang et al., “C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation,” Basic Research in Cardiology, vol. 110, no. 4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Shengkai, J. Hong, W. Bing, Y. Jian, and C. Sisi, “Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway,” Tohoku Journal of Experimental Medicine, vol. 219, no. 4, pp. 283–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Luo, S. Chen, Y. Qin, Z. Chen, and F. Gallyas, “Urotensin-II receptor antagonist SB-710411 protects rat heart against ischemia-reperfusion injury via RhoA/ROCK pathway,” PLoS ONE, vol. 11, no. 1, Article ID e0146094, 2016. View at Publisher · View at Google Scholar
  17. S.-J. Dai, R.-Y. Chen, and D.-Q. Yu, “Studies on the flavonoid compounds of Rhododendron anthopogonoides,” China Journal of Chinese Materia Medica, vol. 29, no. 1, pp. 44–47, 2004. View at Google Scholar · View at Scopus
  18. P.-L. Lei, R.-S. Huang, Q. Su, and Z.-N. Liang, “Quality standard of zhuang medicine jasmini sambacis flos,” Journal of Chinese medicinal materials, vol. 36, no. 5, pp. 731–736, 2013. View at Google Scholar · View at Scopus
  19. J. Kim, E. Sohn, C.-S. Kim, Y. M. Lee, K. Jo, and J. S. Kim, “Effect of KIOM-79 on diabetes-induced myocardial fibrosis in Zucker diabetic fatty rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 547653, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. K.-S. Oh, B. K. Oh, C. H. Park, J. Mun, S. H. Won, and B. H. Lee, “Baicalein potently inhibits Rho kinase activity and suppresses actin stress fiber formation in angiotensin II-stimulated H9c2 cells,” Biological and Pharmaceutical Bulletin, vol. 35, no. 8, pp. 1281–1286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. Kim, K.-S. Oh, J. H. Lee, S. Y. Ryu, J. Mun, and B. H. Lee, “Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of Rho-associated kinase 2 activity,” Biochemical and Biophysical Research Communications, vol. 438, no. 2, pp. 318–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. L. P. Yuan, Z. W. Chen, F. Li, L. Y. Dong, and F. H. Chen, “Protective effect of total flavones of rhododendra on ischemic myocardial injury in rabbits,” The American Journal of Chinese Medicine, vol. 34, no. 3, pp. 483–492, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-H. Zhang, Z.-W. Chen, and Z. Wu, “Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury,” Canadian Journal of Physiology and Pharmacology, vol. 86, no. 3, pp. 131–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Jiao, Y.-F. Fan, Y.-L. Wang, J.-Y. Zhang, S. Chen, and Z.-W. Chen, “Protective effect and mechanism of total flavones from Rhododendron simsii planch flower on cultured rat cardiomyocytes with anoxia and reoxygenation,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 863531, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Wang, J. Zhou, and X. Ding, “Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 6, pp. 6596–6606, 2015. View at Google Scholar
  26. M.-J. Shao, S.-R. Wang, M.-J. Zhao et al., “The effects of velvet antler of deer on cardiac functions of rats with heart failure following myocardial infarction,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 825056, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. W.-W. Bai, Y.-F. Xing, B. Wang et al., “Tongxinluo improves cardiac function and ameliorates ventricular remodeling in mice model of myocardial infarction through enhancing angiogenesis,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 813247, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. G. Sutton and N. Sharpe, “Left ventricular remodeling after myocardial infarction: pathophysiology and therapy,” Circulation, vol. 101, no. 25, pp. 2981–2988, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Euler, “Good and bad sides of TGFbeta-signaling in myocardial infarction,” Frontiers in Physiology, vol. 6, p. 66, 2015. View at Google Scholar
  30. W. A. Border and N. A. Noble, “Transforming growth factor β in tissue fibrosis,” The New England Journal of Medicine, vol. 331, no. 19, pp. 1286–1292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. K. T. Weber, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, and I. C. Gerling, “Myofibroblast-mediated mechanisms of pathological remodelling of the heart,” Nature Reviews Cardiology, vol. 10, no. 1, pp. 15–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. K. M. Herum, I. G. Lunde, B. Skrbic et al., “Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress,” Journal of Molecular and Cellular Cardiology, vol. 54, no. 1, pp. 73–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Gu, X. Wang, X. Wang et al., “Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway,” Tohoku Journal of Experimental Medicine, vol. 227, no. 3, pp. 161–170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Wu, H. Lei, J.-Y. Wang et al., “CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation,” Journal of Molecular Medicine, vol. 93, no. 12, pp. 1311–1325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Hattori, H. Shimokawa, M. Higashi et al., “Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice,” Circulation, vol. 109, no. 18, pp. 2234–2239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Hartmann, A. J. Ridley, and S. Lutz, “The function of rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease,” Frontiers in Pharmacology, vol. 6, article no. 276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Yang, Q. Li, X. Lin et al., “Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1,” The FASEB Journal, vol. 26, no. 5, pp. 2105–2116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Okamoto, Y. Li, K. Noma et al., “FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2,” FASEB Journal, vol. 27, no. 4, pp. 1439–1449, 2013. View at Publisher · View at Google Scholar · View at Scopus